 |
Board of Directors
Peter Katevatis
Peter Katevatis Esq. Co-Founder of Mediscience with Dr. Robert Alfano has served as Chairman of the Board of Directors / legal counsel since 1993. Admitted to the PA. NY,
NJ and DC bar associations. .Mr. Katevatis was a trustee of the New Jersey State's Police and Fireman Retirement Pension Fund 1990-98 and served as a member of the State of
New Jersey Investment Council from 1990 until December, 1992. He serves as a judicial arbitrator for the American Arbitration Association and the National Association of
Securities Dealers (NASD). Mr. Katevatis is also a long-time member of the National District Attorney's Association and a member of the New York Academy of Science.
Sidney Braginsky
He served as President of Olympus America, Chairman of Atropos, Inc., and as a director for Noven Pharmaceuticals, Inc . Mr. Braginsky received his B.S. in biology from
Queens College. Since 2001, he has served as the Chairman and Chief Executive Officer of Digilab, LLC, a spectroscopy instruments manufacturer.
Joseph C. Franchetti
CEO and President, Director of Colin Medical Instruments Corporation, San Antonio, Texas Japanese owned world-leader in non-invasive blood pressure and vital signs
diagnostic and monitoring medical devices responsible for starting, building all North/South American operations From 1989 through 1996 President and CEO/COO of Bio-
Chem Laboratory Systems; in 1996, Joe founded 3 F’s & TBD Company, where he acts as an adviser to medical device company’s. He is is a graduate of the Univ of
Pa.Wharton School of Business.
Michael Engelhart
20-year track record as a successful entrepreneur and senior executive in sales & marketing, business/corporate development, growing distribution channels, and product
development. Michael has served as President, COO and board member for Mediscience Technology for two years. Mr. Engelhart is experienced in management and consulting
of several successful companies in the healthcare field including; WebMD, Vitabiotics, Ltd, Max.Md, Sylkworks, Inc., I2MD, LLC and Den Ventures, LLC. Mr. Engelhart was
the President and CEO of THM Group, LLC, a firm providing strategic consulting services in the areas of business strategy, development and operations and product branding,
launch and development; client list includes, Consolidated Edision, Orange and Rockland Utilties, KN Energy, Reeves International, Channel Space Entertainment, Neptune
Plastics Manufacturing and SAVA Industries.
Dr. Anil Rastogi
A senior executive with diverse leadership experience in several industries & in academic environment managing technology-driven businesses, start-up ventures & successfully
completing IPO. Demonstrated success at commercialization of technology, bringing products from inception to market. Strong skills in establishing global strategic partners.
Strong organization development skills with bottom-line focus and a profit orientation. International experience in European and Pacific Rim markets. Mr. Rastogi is a graduate
of McGill University, Montreal, Canada. He received his Bachelor of Science Degree, Cum Laude from Free University, Brussels, Belgium and his M.D. degree from Free
University as well. In addition to his active role as a practicing New York City physician, specializing in Gynecologic Oncology, his professional experience covers a broad range
of activities in the Research and Development of pharmaceutical products. Specifically, this includes United States consultant to B & A Inc., a company that operates as a service
group for coordinating and organizing clinical trials (Phase I, II, III) in Mexico and throughout Latin America . As Medical Director, Clinical Development Oncology for Daiichi
Pharmaceutical Corp. he was responsible for coordinating and the management of the clinical development of the Company's drug projects with focus on implementing clinical
study protocols, including those for projects in the U.S as well as Mexico and South/Central America. He has been an active participant in the working as a consultant with
Mediscience on the clinical aspects of the CD Ratiometer project.
John P. Matheu
Mr. Matheu has extensive experience in the biopharmaceutical and medical device industries. He served 34 years with Pfizer Pharmaceuticals, Inc., where among other
accomplishments, as Vice President he established and directed Pfizer's generic drug division. Prior to that assignment, Mr. Matheu directed Pfizer's 1100 person sales force, its
hospital marketing group and its training department. As a principal of Matheu Associates, he provides consulting and management advice to the pharmaceutical, biotechnology
and medical device industry.
John Kennedy
Mr. Kennedy is chairman of Audit committee since 2000 and Vice President Secretary and director of the Company, since 1982. Mr. Kennedy is Chairman of the Board CEO,
of Pepco Manufacturing Co., a 30 yr. fabricator for the electronics industry located in Somerdale, New Jersey. Mr. Kennedy served as director and member of the Audit
Committee of First Peoples Bank of New Jersey and as a member of its executive board until 1994 when First Peoples Bank was acquired by Corestates Bank .
|